interesting - search results

If you're not happy with the results, please do another search

0 1568

Hemp, Inc. (OTC PINK: HEMP) executives are pleased to report on the progress of its industrial hemp processing facility in Spring Hope, North Carolina. According to David Schmitt, COO of Hemp, Inc.’s wholly owned subsidiary, Industrial Hemp Manufacturing, LLC, the mechanical installation of the bale shredder was completed last week. “This system starts with a very large metal detection system to insure that there are no metal objects in any of the bales of kenaf or hemp. If the metal detector senses anything metallic, it will shut the system down. This is a safety feature to insure no metal goes into the milling system.”

Schmitt continued, “Next, the bales go up an incline conveyor into the shredder. Here the material is reduced in size to a 1-inch particle. It is then carried on a conveyor into the first stage of the milling operation. We have now started to run conduit and wiring to all of the electric motors on the shredding system. I am anticipating about two weeks to complete the electrical work. The milling operation will then be able to run in a fully automatic mode and we will begin processing the 18 million pounds of kenaf we have in inventory. We have been running the milling operation in a manual mode to confirm operation of all of the motors, sensors, filters, rotary valves, etc. All of the machinery is working properly.”

The company is working to get their hemp seed into North Carolina so that the first hemp crop can be planted in the next few weeks. “Our Nuaxon super critical CO2 extraction machine is scheduled to be delivered next week. We must then build a GMP compliant building to house the extraction unit as well as all of the post processing equipment. Once this is done, we will begin installation and commissioning of the extraction machine to begin producing CBDs,” said Schmitt.

The industrial hemp industry is burgeoning into one of the fastest growing industries in America, along with its distinct counterpart, marijuana. The American attitude on marijuana usage has been undergoing a seismic shift over the past couple of years as more states are legalizing it and realizing the economic benefits of legalization. Like its conservative cousin (industrial hemp), marijuana is big business with potentially billions of dollars to be made. Small growers, advocates, and big businesses alike are battling it out with the American justice system to bring marijuana mainstream.

Today, this massive growth curve and economic boom is for marijuana. Tomorrow, it will be for industrial hemp. While thousands of people have joined the lucrative marijuana business, only a handful are pioneering the industrial hemp industry. The following facts are indicators of what is to come for industrial hemp, putting Hemp, Inc. (OTC PINK: HEMP) an easy 5 years ahead of the curve.

It’s been called “The Marijuana Revolution” and here are 25 interesting facts you may not have known:

• The North American marijuana market posted $6.7 billion in revenue in 2016, up 30% from the year before. U.S. legal sales could reach $50 billion by 2026. (source)
• Colorado has collected more than $150 million in taxes from legal marijuana sales, including nearly $50 million from a specific excise tax that directs funds to school construction projects. The first $40 million collected annually from the excise tax is earmarked for the school projects. (source)
• Fifty-seven percent of Americans supported legalizing marijuana in 2016 compared to just 52 percent of the country in 2014. Support for legal cannabis has been steadily increasing among Americans since 2006 when it reached 35 percent. (source)
• By 2020 it is estimated that country-wide legal marijuana sales will generate more annual revenue than the National Football League. (source)
• Cannabis is the largest cash crop in the United States, exceeding corn and wheat combined. (source)
• The first e-commerce transaction to take place on the Internet was the sale of cannabis. (source)
• In Colorado, medical marijuana dispensaries outnumber Starbucks locations three to one. (source)
• A pot smoker would theoretically have to consume nearly 1,500 pounds of marijuana within about fifteen minutes to induce a lethal response. (source)
• Research has found that Δ(9)-tetrahydrocannabinol, also known as THC (the main active component of marijuana), has a growth-inhibiting effect on the cancer cells in liver. (source)
• The word “canvas” is derived from the word “cannabis” because canvas used to be made from hemp fiber. The ropes, sails, and caulking of the Mayflower were all made from hemp fiber. (source)
• Marijuana seeds are a source of all amino acids. They are one of only a handful of substances that man can sustain off indefinitely with no other food and provide all known amino acids. (source) Hemp seeds are an excellent 3:1 balance of omega-3 and omega-6 fatty acids, which promote cardiovascular health and are high in gamma linolenic acid (GLA), an essential omega-6 fatty acid found in borage oil and egg yolks that has been proven to naturally balance hormones. (source)
• The University of Mississippi operates the United States’ only legal marijuana farm, on behalf of the government. (source)
• The difference between hemp and pot is a single genetic switch. In 2011, researchers from the University of Saskatchewan announced that they’d discovered the genetic alteration that allows psychoactive cannabis plants (Cannabis sativa) to give users a high (as compared to industrial hemp plants, which are no fun for smoking). Industrial hemp plants are the same species as marijuana plants, but they don’t produce a substance called tetrahydrocannabinolic acid (THCA). This is the precursor to tetrahydrocannabinol (THC), the psychoactive ingredient in pot. Hemp plants fail to produce this substance because they lack a gene that makes an enzyme to produce THCA, according to University of Saskatchewan biochemist Jon Page. In contrast, marijuana plants do produce THCA but don’t create much of a substance called cannabidiolic acid (CBDA), which occurs in abundance in hemp but competes with THCA for raw materials. Thus, hemp is rich in nonpsychoactive CBDA, while marijuana is chock full of mind-bending THC. (source)
• In 2016, researchers measured the levels of marijuana’s active ingredient, THC, in more than 38,600 samples of street marijuana seized by the Drug Enforcement Agency over 20 years. They found that the levels of THC rose from about 4 percent in 1995 to about 12 percent in 2014. (source)
• Both Thomas Jefferson and George Washington grew hemp on their plantations. The British crown even ordered the colonists to grow the plant. (source)
• Since 2015, marijuana has become the fastest growing industry in the U.S. If marijuana becomes legal in all 50 states, the industry will become larger than the organic food market. (source)
• During the temperance movement of the 1890s, marijuana was commonly recommended as a substitute for alcohol. The reason for this was that use of marijuana did not lead to domestic violence while alcohol abuse did. (source)
• Paraguay is believed to be the world’s largest producer of marijuana. (source)
• Twenty-three percent of people who visited Colorado in 2015 said the availability of marijuana positively influenced their decision to vacation in the state. (source)
• Since the legalization of marijuana in Colorado, highway fatalities have hit a historic low. (source)
• The first two drafts of the United States Declaration of Independence were written on paper made from hemp. (source) Bob Crumley, founder of Crumley-Roberts Attorneys at Law, and the NC Industrial Hemp Association says the first 5 Presidents of the United States were all hemp farmers. (source)
• The very first thing sold online was a bag of weed. It took place in 1971 at Stanford. Students used the internet, then Arpanet, to make the transaction. (source)
• Marijuana mimics your body chemistry. Marijuana’s active ingredient, THC, is shaped very closely and acts similarly to anandamide, which your body naturally produces. It is part of the endocannabinoid system that plays a role in regulating mood, sleep, and appetite. (source)
• Like people, animals with debilitating diseases can also get help from cannabis’ medical properties. Veterinarians have reported improved health in cats and dogs who suffer from anxiety and seizures that have been prescribed medical marijuana products like Canna-Pet and other non-psychoactive cannabis-based tinctures. (source)
• The Jamestown colony in 1619 passed legislation forcing settlers to grow cannabis. Hemp was a mainstream cash crop that was used to make rope, fabric and ship sails. It was literally against the law not to grow it. (source)

Bruce Perlowin, CEO of Hemp, Inc. (OTC PINK: HEMP) said, “This migration from marijuana to hemp is prevalent everywhere I go. Most large hemp growers got their start by growing marijuana and just like us migrated from that sector into the new promising industrial hemp where the pioneers all have ‘First Mover’s Advantage’. I see this in every state I go to from California to Oregon to Nevada to Kentucky (but not North Carolina for some reason).”

As the marijuana industry continues to find its place and settle in mainstream America, so will industrial hemp. Senate Bill 1726, that was filed with the Florida state senate last month, has been placed on the senate’s Special Order Calendar for today. The bill authorizes the Department of Agriculture and Consumer Services to oversee the development of industrial hemp pilot projects for the Institute of Food and Agricultural Sciences at the University of Florida and the Florida Agricultural and Mechanical University and authorizes the universities to develop the pilot projects in partnership with public, nonprofit, and private entities.

The legalization of industrial hemp has a strong possibility of passing. Today, Floridians are aware of the need to diversify their state’s economy, thus Senate Bill 1726 and related House Bill 1217, have an excellent chance of passing.

Bruce Perlowin, CEO of Hemp, Inc. (OTC PINK: HEMP) said, “It’s time for hemp to make its rightful return to the American landscape. Florida is another step closer to being the next state. As home to the largest, commercial, industrial hemp decorticating facility, Hemp, Inc. is also pleased to be a part of the industrial hemp movement and making America great again by making America hemp again.”

In other industrial hemp news, Missouri House Bill 170, as of 2 days ago, the executive session (senate) voted “do pass”. As previously reported on 4/12/17, HB 170 passed the state house with a 126 – 26 vote in favor of legalizing industrial hemp, yesterday, and has been passed to the state senate for the senate’s first read. HB 170 would allow those licensed by the Department of Agriculture to grow, harvest, and cultivate industrial hemp. According to a recent article, “supporters call the bill a development opportunity that could be a boon for farmers and help cultivate new business.” Under the proposal, people who want to grow hemp must apply with the Department of Agriculture and submit to a background check. Crops would also be subject to inspection.

The 900-member North Carolina Industrial Hemp Association (NCIHA) is a 501(c)(6) trade organization that represents all the stakeholders helping to build a thriving hemp industry in North Carolina. The NCIHA is responsible for the lobbying effort behind the passage of the North Carolina Industrial Hemp Pilot Program. Through education, dedication and fundraising, North Carolina can be accelerated to the forefront of global growth in Industrial and Medicinal Hemp. North Carolina can and should lead the country in cultivation, processing and support the consumption of hemp’s many beneficial products. Hemp was, for almost 200 years, a legal and fundamental crop in North Carolina and should be again.

Visit for more information. To join the North Carolina Industrial Hemp Association, click here.

Arizona. As reported by Hemp, Inc. on 2/22/17, Arizona State Legislature, SB1337, that was in review by the Senate has passed the Senate with a 26-4 with bipartisan support in the Senate and is now in the House for consideration. SB 1337, if passed, would legalize the production, processing, sale and distribution of industrial hemp for commercial purposes.

Whether it’s Alaska or Arizona, Hemp, Inc. is on the ground more often than not conducting business in those states. In Arizona, for example, Hemp, Inc. plans to grow up to 300 acres on a 500-acre Veteran Village Kins Community.

Aligned with Hemp, Inc.’s Triple Bottom Line approach, CEO Bruce Perlowin is exploring the possibilities of developing “Hemp Growing Veteran Village Kins Communities” in North Carolina and considering several other states similar to the 500-acre demonstration community being built in Arizona. He currently has 2,500 acres (and counting) of land in Kingman, Arizona where he’s building a veteran village on 500 of those acres that would consist of 160 lots of 2 1/2 acre parcels for Kins Domains (eco-villages). Each parcel would grow 1 acre of hemp as well as having organic gardens, natural beehives, a pond, a living fence and other elements that make up a Kins Domain.

An additional 100 acres of hemp will be grown in each one of these 500-acre communities. The revenue from fifty of those acres is used to support that community. The revenue from the other fifty acres of hemp will be used to purchase 2 additional 500-acre parcels of land, thus keeping up with the needs of a large number of veterans that exist now and in the future.

The eco-friendly “Veteran Village Kins Communities” were inspired by the book series, The Ringing Cedars of Russia ( Perlowin has since found a way to incorporate it into Hemp, Inc.’s strategy of building hemp growing, CBD-producing “communities” or “villages.” The first part of these “Veteran Village Kins Communities” is a “holistic healing and learning center” whose function in each community is obvious by the title. The prototype Veteran Village Kins Community in Arizona is expected to be completed by mid-2017.

Perlowin has been personally creating the Arizona “Veteran Village Kins Community” since 2013 as a solution to America’s multifaceted veteran problem. To date, forty-four percent of the homeless are veterans. Twelve percent of that group are combat woman veterans with children. Twenty-two veterans commit suicide EVERY DAY. Two million veterans are on food stamps. As for the future, 238,000 veterans are leaving the armed services every year.

From rehabilitation to job creation, Perlowin says this model presents a comprehensive holistic solution to those individuals that all Americans owe a great debt of gratitude towards… the American veterans. Perlowin expects this model to produce very lucrative revenue for Hemp, Inc., the veterans themselves and the local communities these Kins Communities are built near. “The infrastructure for ‘The Hemp Growing, CBD-Producing, Veteran-Village Kins Community,’ which takes time to build, is already in place in Arizona. I’ve been building this infrastructure since 2013 and it can be duplicated for any state,” says Perlowin.

To see a series of videos on what a Kins Domain is, visit

Hemp is a durable natural fiber that is grown as a renewable source for raw materials that can be incorporated into thousands of products. It’s one of the oldest domesticated crops known to man. Hemp is used in nutritional food products such as hemp seeds, hemp hearts and hemp proteins, for humans. It is also used in building materials, paper, textiles, cordage, organic body care and other nutraceuticals, just to name a few. It has thousands of other known uses. A hemp crop requires half the water alfalfa uses and can be grown without the heavy use of pesticides. Farmers worldwide grow hemp commercially for fiber, seed, and oil for use in a variety of industrial and consumer products. The United States is the only developed nation that fails to cultivate industrial hemp as an economic crop on a large scale, according to the Congressional Resource Service. However, with rapidly changing laws and more states gravitating towards industrial hemp and passing an industrial hemp bill, that could change. Currently, the majority of hemp sold in the United States is imported from China and Canada, the world’s largest exporters of the industrial hemp crop.

To see the video showcasing the dramatic footage of our hemp and Kenaf grows, click here.

To see 1-minute daily video updates (from Hemp, Inc. CEO Bruce Perlowin) on the final phases of completion of Hemp, Inc.’s 70,000 square foot industrial hemp processing facility and milling operation and other developments, click here. (Remember to scroll down to see the other videos of this historical event of building an American industrial hemp processing facility and factory from the ground up.)

Fuel. While the industrial, medicinal and commercial properties of hemp have been known to mankind for a very long time, its benefits to the environment have just been realized in recent years. One of the compelling things hemp offers is fuel. Reserves of petroleum are being depleted. Right now we are depleting our reserves of petroleum and buying it up from other countries. It would be nice if we could have a fuel source which was reusable and which we could grow right here, making us completely energy independent.

Industries in search of sustainable and eco-friendly processes are realizing hemp as a viable option. Hemp can provide an alternative, more efficient source of energy in the fuel industry. “The woody hemp plant is low in moisture; it dries quickly and is an efficient biomass source of methanol. The waste products produced by using hemp oil are a good source of ethanol. Both methanol and ethanol are produced from hemp through the efficient and economical process of thermo-chemical conversion. One acre of hemp yields 1,000 gallons or 3,785 liters of fuel. Hemp allows a lesser reliance on fossil fuels, which are non-renewable sources of energy and will not be able to meet the increasing global demands for long.

Petroleum fuel increases carbon monoxide in the atmosphere and contributes heavily to global warming and the greenhouse effect, which could lead to global catastrophe in the next 50 years if these trends continue. Do you want to find out if they are right, or do you want to grow the most cost effective and environmentally safe fuel source on the planet?

Using hemp as an energy and rotation crop would be a great step in the right direction.
To see 1-minute daily video updates (from Hemp, Inc. CEO Bruce Perlowin) on the final phases of completion of Hemp, Inc.’s 70,000 square foot industrial hemp processing facility and milling operation and other developments, click here. (Remember to scroll down to see the other videos of this historical event of building an American industrial hemp processing facility and factory from the ground up.)

1. The Hemp University’s Farming HEMP for Profit (April 29, 2017 in Spring Hope, North Carolina)
The Hemp University will be doing its second event for landowners, farmers, entrepreneurs and investors. This will also be the last “introductory” event, as following classes will be focused on a high-end technical education series. These will be similar to what you would expect for experienced professionals in their fields or those wanting the latest information on a specific topic.

2. Marijuana Business Conference and Expo (May 16 – 19, 2017 in Washington, DC)
The Marijuana Business Conference and Expo is the largest gathering business community of mid to large wholesale growers, dispensaries and recreational retailers, infused product makers, ancillary companies ranging from grow technology to legal services, and, angels and VCs investing in privately-held firms. The conference highlights the latest advances and networking opportunities in the cannabis industry. MJBizCon, as it is referred to, has continued to set industry-wide attendance records and is by far the world’s largest gathering of executives and exhibitors each and every season. The show continues to be curated by the editors of MJBizDaily, the industry’s most trusted professional news service. The upcoming expo expects 3,500-4,000 attendees from all 50 states and more than a dozen nations including a large Canadian contingent.

3. The Hemp University’s Farming HEMP for Profit (May 27, 2017 in Spring Hope, North Carolina)
The Hemp University will launch the first of these events focused on Greenhouse and Indoor Growing. As May/June mark the end for the outdoor planting season, The Hemp University will bring the best in class Greenhouse and Indoor Growing experts to educate and train attendees on the opportunities, challenges and what is needed to succeed.

4. Hemp on the Slope (July 22, 2017 at Salt Creek Ranch in Collbran, CO from 11:00am to 5:00pm)
Presented by Salt Creek Hemp Co. and produced by the Colorado Hemp Company, this celebration will feature speakers, workshops, exhibitors, live music, hemp food, networking and more. Hemp on the Slope seeks to educate and inform the community on the amazing benefits of hemp and the economic opportunities that exist. This event is hemp-centric and focused on all of the industrial, nutritional, and nutraceutical benefits of non-psychoactive cannabis-hemp. This event is not a medical or recreational marijuana event.

Those who attend the upcoming Hemp on the Slope! event in Colorado will be able to see Hemp, Inc.’s 17,000 CBD clones growing up close. Dr. Michael Villa, CEO of Innovations in Science and Business Research and Development, based in Colorado, is in negotiations with Hemp, Inc. for the planting, harvest and purchase of 17,000 high CBD-rich hemp clones. According to Dr. Villa, his company will be growing 17,000 plants for Hemp, Inc. in Colorado for CBD production. The clones will be made up of 8 different strains and is expected to be planted in late May of this year and harvested late September/early October. The crop will be dried and processed in Colorado. The CBD oil, to be extracted, will be prepared for the nutraceutical market. There are to be 1,000 plants per acre so the total crop will cover 17 acres. The whole process is expected to create jobs for up to 25 people or more. Taking into account the infrastructure, testing facilities and retail outlets, Colorado can expect a nice influx of job creation for its economy.

5. Cannabis World Congress and Business Exposition (June 14 – 16, 2017 in New York, New York; September 13 – 15, 2017 in Los Angeles, California; and October 4 – 6, 2017 in Boston, Massachusetts)
The Cannabis World Congress & Business Expo (CWCBExpo) is the definitive business event for the cannabis industry. Exhibitors and sponsors bring cutting-edge solutions to owners and managers of businesses in this fast-growing industry, and a wealth of opportunity and knowledge to those looking to enter the market with potential partners and investors.

The Northeast CWCBExpo (New York) will offer the depth and breadth of information and products for these industries expected to top $20 billion in the next three years. There is a huge platform taking a more comprehensive approach to learning with a strong emphasis on industrial hemp due to Governor Cuomo’s commitment to making hemp a $1 billion industry in New York. The “Make America Hemp Again” will be presented by Hoban Law Group/CPS Education.

6. The Hemp University’s Farming HEMP for Profit (June 24, 2017 in Spring Hope, North Carolina)
The Hemp University will bring you The Art and Science of Extraction. Potentially the greatest single opportunity in the cannabis industry are the products created via extraction. With over 120 currently discovered cannabinoids and terpenes in cannabis — extraction and refinement are paramount to creating top tier consumer products.
To list your hemp event here, email

“Hemp, Inc. Presents” is capturing the historic, monumental re-creation of the hemp decorticator today as America begins to evolve into a cleaner, green, eco-friendly sustainable environment. What many see as the next American Industrial Revolution is actually the Industrial Hemp Revolution. Watch as Hemp, Inc., the #1 leader in the industrial hemp industry, engages its shareholders and the public through each step in bringing back the hemp decorticator as described in the “Freedom Leaf Magazine” article “The Return of the Hemp Decorticator” by Steve Bloom.

Freedom Leaf Magazine, one of the preeminent news resources for the cannabis, medical marijuana, and industrial hemp industry in America, is published by Freedom Leaf, Inc., a fully reporting, audited, publicly traded company on OTC Markets. Stay in the loop with Freedom Leaf Magazine as it continues to deliver the good news in marijuana reform with some of the most compelling art, entertainment, and lifestyle-driven industry news in the cannabis/hemp sector. On the go? Download the Freedom Leaf mobile app to stay connected as they transform the delivery of cannabis news and information across the digital landscape. Get the mobile app on Apple iOS or Google Play.

“Hemp, Inc. Presents” is accessible 24 hours a day, 7 days a week, by visiting To subscribe to the “Hemp, Inc. Presents” YouTube channel, be sure to click the subscribe button.

NHA represents hemp farmers, processors, manufacturers, start-up businesses, entrepreneurial endeavors, and retailers and strives to build a viable industrial hemp economy by providing education about the benefits of hemp and providing expert consultation to producers and processors entering the hemp industry. NHA has developed close relationships with local and state government agencies to establish regulations that benefit the hemp industry across the nation. We provide a wealth of expertise in fields ranging from mining and agriculture to hemp materials processing and the latest developments pertaining to laws and regulations. For more information on the National Hemp Association, visit

The Hemp Industries Association (HIA) is a non-profit trade association representing businesses, farmers, researchers and investors working with industrial hemp. The HIA is at the forefront of the drive for fair and equal treatment of industrial hemp. Since 1994, the HIA has been dedicated to education, industry development, and the accelerated expansion of hemp world market supply and demand. For those who are currently involved in the hemp industry, thinking of starting a hemp business, a farmer interested in hemp or to support hemp commerce, please consider becoming a member of the HIA. To join, please click here for benefits, more information and an application.

With a deep-rooted social and environmental mission at its core, Hemp, Inc. seeks to build a business constituency for the American small farmer, the American veteran, and other groups experiencing the ever-increasing disparity between tapering income and soaring expenses. As a leader in the industrial hemp industry with ownership of the largest commercial multi-purpose industrial hemp processing facility in North America, Hemp, Inc. believes there can be tangible benefits reaped from adhering to a corporate social responsibility plan. Thus, Hemp, Inc.’s “Triple Bottom Line” approach serves as an important tool in balancing meeting business objectives and the needs of society and environment at the same time.

SOCIAL NETWORKS: (Twitter) (Facebook) (Investors Hangout)

To see the video showcasing the dramatic footage of our hemp and Kenaf grows, click here.

To see 1-minute daily video updates (from Hemp, Inc. CEO Bruce Perlowin) on the final phases of completion of Hemp, Inc.’s 70,000 square foot industrial hemp processing facility and milling operation and other developments, click here. (Remember to scroll down to see the other videos of this historical event of building an American industrial hemp processing facility and factory from the ground up.)

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

For Investor Relations, please send correspondence to:
• Hemp, Inc.
(855) HEMP-OUT

0 2736

2017 has really been the year for marijuana in the united states, 28 different states have led the initiative in the legalization of its medicinal use. The real beauty starts to exert itself when you look at all the goods that are a product of its harvest, because when broken down weed can be used as hemp for physical products or for its medicinal cannabinoid but either way they are becoming more and more present in households today.

Without adieu here are the top 10 marijuana trends in no particular order

1. Personal Home grow solutions

As marijuana continually becomes more accepted in households, people are starting to grow their own marijuana. This opens a new market for companies that create solutions for home growing. States are also becoming more lenient as to the amount of plants you can have. for example, in Maine each household is allowed to have 12 plants and in Alaska it is double that. Since growing marijuana indoors is extremely heavy on the utility bills a lot of companies have been trying to create different methods for us to harvest marijuana without racking up a hefty electricity bill.

2. Delivery

The next big thing that is growing a lot in recent news are marijuana delivery services, just as companies like uber-eats and grub hub make food delivery a one-click mission. Companies like California cannabis delivery startup Eaze have gathered more than 25 million dollars in multiple rounds of financing in order to become the largest provider of on-demand cannabis. As they do remain ahead numerous delivery services are trying to copy Eaze’s business model to service what will be the worlds largest recreational cannabis economy.

3. Weed TV shows

Aside from marijuana having the most famous cameos in television today. This makes a lot of room for marijuana based television shows. Unlike weeds, these shows are taking place in a different America meaning that they have a vast consumer base which will facilitate its growth. Who doesn’t like a good stoner tv show.

4. Synthetic CBD

Another market that is growing rapidly is the harvesting of synthetic CBD, although this technically doesn’t have marijuana in it, it is a product of the controversy against CBD products. Every single day companies like Corbus pharma(OTC:CBRP) struggle with the FDA in attempting to green light synthetic CBD based medicine. Their drug Resunab, currently in phase 3 testing, is said to be released in 2019 as one of the best CBD alternative medicines today.

5. Craft marijuana

Like alcohol, people are beginning to see the differences in different marijuana depending on its source. This opens up a new lane for artisanal medicinal marijuana as people are beginning to smoke lavishly packaged strains and medicinal products. Companies like défoncé chocolates make luxury chocolate bars that just so happen to be medicated with quality cannabis. Every day more cannabis companies are beginning to embrace the farm-to-table approach for marijuana, this will continually open a path for craft-weed.

6. Safer/easier consumption

the biggest controversy today with marijuana is the methods of which it is consumed. Because smoking is so shunned upon in todays world. Many companies have been making the move to safer consumption both for recreational and medicinal relief. Portable vaporizers like the PAX 3 and the Puffco plus allow consumers to discretely inhale marijuana while on the go. As edibles also provide longer/more therapeutic doses a lot of companies are moving to uniquely packaged and marketed edibles for mass-consumption.

7. Micro dosing

Micro dosing is a great way to receive a lot of medicinal marijuana benefits without the high that is usually associated with THC. Companies like Kiva Confections have been creating micro-dose friendly products that are uniquely packaged for the masses. Recent studies have actually indicated that micro dosing might actually have more of a positive effect than macro dosing, that being said this market is poised for growth during 2017.

8. Sports

Today many athletes like Ronda Rousey and Ricky Williams have become advocates for stopping marijuana testing in sports leagues to allow athletes to use marijuana as medication. Many professional athletes turn to the use of medicinal marijuana to treat pain and head injuries as they continue to reject opiate-based prescribed medicine

9. Product design

Although most of the products in this industry were made based on utility , the tables are beginning to turn as style becomes more present in a variety of products. The world of glassware is also receiving a makeover as visionaries like marijuana activist jane west recently raised a million dollars in capital for a new glassware collection, it’ll be very interesting to see the stylistic choices of vendors as marijuana gets more trendy by the day.

10. Los Angeles as the new marijuana capital

Its time for Denver to move over, there’s a new capital for marijuana according to Medmen capital CEO Adam Biermen. As the marijuana market in Los Angeles amounts to roughly 1 billion dollars, easily overshadowing the mile high city. The city is actually expected to pass a law that clears the path for a proper marijuana licensing program which will open up the flow into the recreational market.

0 236

New Frontier Data & MassRoots Partner on First Cannabis Consumer Sentiment Report

“We have been looking at consumer sentiment in various forms from our own national survey to our ingestion of social media data from multiple platforms. Over the past two years New Frontier Data has been working diligently to understand evolving attitudes, perceptions and use of cannabis. This partnership will allow us to take that research one step further and provide the industry with a deeper understanding of this vastly complex market,” said Giadha Aguirre De Carcer.

“Over the past three years, we’ve built a community of over a million of the world’s most passionate cannabis consumers. In conjunction with New Frontier Data, we’re releasing the first cannabis consumer sentiment report, which will analyze the hundreds of millions of anonymized data points surrounding cannabis purchasing decisions,” stated MassRoots Chief Executive Officer Isaac Dietrich. “This information is invaluable to businesses and brands looking to market to the tens of millions of cannabis consumers in the United States and abroad.”

Our executive team possesses the skill, experience, and knowledge necessary to analyze the depth of data that MassRoots can provide us. New Frontier Data recently poached a pioneer and veteran of the technology sector. Prior to joining as Chief Operating Officer, Gary Allen began his career in the mid 90s pioneering mobile banking with ABN-AMRO, then went on to multiple ad tech successes from affiliate marketing to market leading search technology with Performics and DoubleClick.

“The combination of the industry analytics and reporting from New Frontier Data and the consumer understanding the cannabis social giant MassRoots provides us interesting technology analysis and engagement opportunities. As the cannabis industry continues to mature leading technologies such as the MassRoots social application and New Frontier Data’s Equio platform will provide investors, consumers, operators, and marketers exciting opportunities to connect and understand each other,” said Gary Allen, New Frontier Data COO.

The collective data, analytics, and reach of the New Frontier Data and MassRoots team provide a unique insight into the purchasing patterns of loyal cannabis consumers.

About New Frontier Data:
New Frontier Data is an independent, technology-driven analytics company specializing in the cannabis industry. We offer vetted data, business intelligence and risk management solutions for investors, operators and policymakers. New Frontier’s data and reports have been cited in over 45 countries around the world to inform industry leaders. Founded in 2014, New Frontier is headquartered in Washington, D.C. and an additional office in Denver. For more information or media inquiries, please visit or contact Gretchen Gailey at 202-489-3821 or

About MassRoots, Inc.
MassRoots is one of the largest technology platforms for the regulated cannabis industry. The Company’s mobile apps enable consumers to make educated cannabis purchasing decisions through community-driven reviews. MassRoots is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. For more information, please visit

0 737
Marijuana Stocks

The cannabis train has left the station and this has left states searching for solutions to best capitalize on this emerging opportunity.

Last week, Michigan announced the creation of an agency to centralize all aspects of cannabis industry in the state. The agency dubbed the Bureau of Medical Marijuana Regulation believes that a centralized service will streamline cannabis regulations and allow businesses to operate more efficiently.

This development is exciting as it represents a significant change in the way cannabis is regulated by states. We expect this program to be closely watched by other states and its progression will something to keep an eye on.

LARA Director Shelly Edgerton said, “BMMR’s organizational structure puts Michigan at the forefront of state medical marijuana regulation. Many other states have various licenses and patient programs spread throughout different departments and agencies.”

Cannabis Support at All-Time Highs

Cannabis support in the United States has grown significantly over the last two years and we are reaching a tipping point. Despite the increased support, concerns among cannabis supporters have increased following recent commentary from the newly appointed Attorney General Jeff Sessions.

March data from the General Social Survey showed growing support for legal cannabis in the United States. The number of Americans who think cannabis use should be legal increased to 57% from 52% in 2014.

Another interesting finding from this data pertains to the growing number of people (70%) against the federal government’s enforcement of prohibition laws in states that have legalized cannabis.

1 1456

The emergence of the cannabis industry has led to the creation of sub-industries within it and this has created numerous opportunities for investors.

One sub-industry we find to be very attractive is biotech and this is due to the potential development of numerous billion dollar products.

The potential medical benefits of cannabis can no longer be ignored as agencies like the National Cancer Institute (NCI) continue to recognize its potential. In 2015, the NCI updated its website to include various studies that reveal how cannabis may inhibit tumor growth by killing cells.

Betting on Biotech

Although the biotech industry offers a lot of opportunity, it presents even more risk. When we look at biotech investment opportunities, we look for companies that possess a competitive or unique advantage over their peers.

Last week, one of the biotech companies we have been monitoring closely, Nemus Bioscience (NMUS), announced that it will be advancing the development of a human-dosage suppository formulation of NB1222 with Catalent Pharma Solutions. The product candidate is the proprietary prodrug of tetrahydrocannabinol (THC).

NB1222 has been synthetically manufactured and is being developed to treat and manage chemotherapy-induced nausea and vomiting (CINV). Nemus also plans on advancing this prodrug into formulation activity for the glaucoma indication using its NB1111 candidate molecule.

Today, Nemus signed a development agreement with United Kingdom-based Nanomerics to develop a topical ocular formulation of tetrahydrocannabinol-valine-hemisuccinate (THCVHS), the prodrug of THC, the active component of Nemus drug candidate NB1111 being developed for glaucoma.

The goal of the agreement is to conduct initial studies assessing the preparation of clinical-grade eye drops using the patented Molecular Envelope Technology (MET) developed by Nanomerics.

According to the agreement, work will commence on a future date determined by Nemus. The date is expected to be related with its development plans and corporate objectives.

Nemus Bioscience CEO Brian Murphy said, “Should we find success in formulating NB1111 using Nanomerics’ MET, we could also examine its application using our proprietary Nemus ophthalmic analogue of CBD (NB2222). Our company objective is to establish strategic partnerships utilizing a diverse cannabinoid-based ocular platform to address multiple types of eye disease.”

A Stock to Watch

Nemus Bioscience is an interesting company to watch due to its valuation, product pipeline, and its strategic partnership with the University of Mississippi. The university has been the sole provider of cannabis for medical research through a partnership with the National Institutes of Health since 1968.

We are favorable on this update as it shows further execution by Nemus. The company’s strategic relationship with Federal agencies makes it an attractive opportunity for investors and a stock to watch.

1 5306

Cannabis stocks have come down from their recent highs and this has raised some concerns after we ended 2016 on a high note.

2016 was a great year for the cannabis industry and we expect 2017 to build off this success. From Canada to Australia, the United States to Germany, the global cannabis industry continued to expand and the stage is set for growth for years to come.

The recent weakness has led to an influx of questions pertaining to the top cannabis investment opportunities and we want to highlight 7 cannabis stocks that investors should watch during 2017.

Seven Cannabis Stocks to Watch

1. GW Pharmaceuticals (GWPH): We continue to view GWPH as the top long-term biotech investment levered to the cannabis industry and we expect to see a VERY STRONG second half of the year. We are favorable on the long-term outlook due to its deep pipeline of products in advanced stages of clinical trials, its strong balance sheet, and its favorable Wall Street coverage.

2. Zynerba Pharma (ZYNE): We consider the company to be one of the most undervalued biotech investment opportunities. Zynerba is focused on developing treatments from synthetic cannabis and the average Wall Street price target offers almost 100% upside to current levels.

3. Canopy Growth (WEED.TO) (TWMJF) continues to be the leader in the Canadian medical cannabis industry and view the company as one the best opportunities within the cannabis industry. The shares have been trending lower and we view this weakness as a great opportunity to buy into a high-quality cannabis producer with a global footprint.

4. Emblem Corp. (EMC.V) (EMMBF) has been trending so far this year and the shares are down 30% during this time. Despite the recent weakness, we are bullish on the company’s opportunity due to its attractive business model, its proven management team, its sound financial structure, its strong balance sheet, and its leverage to growth trends in the cannabis sector

5. After securing a potentially highly lucrative licensing contract, InMed Pharmaceuticals, (IN.CN) (IMLFF) looks even better positioned to benefit for positive tailwinds facing the global cannabis industry. InMed is a pre-clinical biopharmaceutical company that is focused on the research and development of novel and cannabinoid-based therapies in Canada. The company has a strong pipeline of products in various stages of FDA testing and is developing various drugs for diseases, such as ocular, pain and inflammation.

6. VPR Brands, LP, (VPRB) is a stock to watch as it is levered to several growth trends within the global cannabis industry. The shares have pulled back and we see upside to current levels. In 2016, VPR acquired Vapor Corp’s wholesale operations and assets for a significant discount and recent announcements show that VPR has executed on and monetized this acquisition. We view this as a very attractive growth story that is undervalued by the street.

7. Vinergy (VIN.CN) (VNNYF) has been one of the most interesting and exciting stories to watch over the last six months and we see significant upside to current levels. The shares have fallen more than 33% in the last month and we find them to be attractive due to the number of catalysts for growth over the next year.

Pursuant to an agreement between MAPH and InMedPharmaceuticals., we were hired for a period beginning February 24 2017 and ending April 24, 2017 to publicly disseminate information about (IMLFF) including on the Website and other media including Facebook and Twitter. We are being paid $40,000 (CASH) for and were paid “250,000” shares of restricted common shares of InMed Pharmaceuticals.Pursuant to an agreement between MAPH and VPRBrands, we were hired for a period of 90 days to publicly disseminate information about (VPRB) including on the Website and other media including Facebook and Twitter. We are being paid $45,000 (CASH) for or were paid “ZERO” shares of unrestricted or restricted common shares. We own zero shares of (VPRB) which we purchased in the open market. Pursuant to an agreement between MAPH and Vinergy Resources, we were hired for a period of 2 months to publicly disseminate information about (VNNYF) including on the Website and other media including Facebook and Twitter. We are being paid $120,000 (CASH) for or “ZERO” shares of restricted or unrestricted common shares. We own zero shares of (VNNYF) which we purchased in the open market. We may buy or sell additional shares of (IMLFF, VPRB, VNNYF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.

0 10878
cbd stocks

List Of CBD Stocks To Watch

For a fairly new market, the Marijuana industry has been embracing unprecedented levels of growth over the past decade. The surge had every investor frantically logging in to their e-trade accounts trying to find the next big Marijuana stock. Although the previous focus of the medical companies was based on the harvesting of the THC component of Marijuana, many have recently discovered the true health benefits of Cannabidiol; a part of the plant that only holds its health benefits and not those that get you ‘high’.

cbd stocks

The recent deregulation and legalization patterns that every state has been following over the past decade are only a testament to how close the United States is to nation-wide legalization. In addition to the whopping 23 states who have already legalized marijuana, there are 15 other states that have legalized the sale of medicinal.

Marijuana businesses in Colorado, which voted to legalize the drug recreationally in 2012, reported about $1.1 billion in legal sales of medical and recreational marijuana and related products last year through the month of October, according to the tax data from the state’s Department of Revenue. That number easily tops the roughly $996 million in total marijuana revenue the state reported in 2015. With this has come an increase in awareness across the board and one of the hottest topics right now has been CBD.  Based on the attention the industry is getting, it seems fitting to highlight some of the most active CBD stocks to watch this year. Here are several CBD stocks on our own list:

Ubiquitech Software Corp (UBQU)

Ubiquitech Software Corp’s main subsidiary, focuses on the sale of CBD products through their network of International growers.

This week the company released earnings guidance for the quarter giving high expectations for year over year growth. Management is anticipating a 50% increase in revenue for the quarter compared to last year.

The company anticipates that revenues for the quarter ended February 28, 2017 will increase over 50% from $697,640 in the first quarter of last year to approximately $1,050,000. The revenue growth is due primarily to the continued acceptance and increased exposure of the HempLife Today™ product line.

“We are excited to show what we have achieved over the past few years,” said James Ballas, CEO, “and we pride ourselves on our process of delivering a superior product at a cost that makes our products available to the widest possible audience. Because, it is this process that makes our company continue to grow.”

This is in addition to the growth that the company has seen already. Earlier this year, UBQU announced its fourth quarter and fiscal year end 2016 financial results. Revenues for the quarter increased to $1,225,015 and to $3,493,113 for the year. Earnings increased 840% from the previous year to $334,350 from $39,651 in 2015. To date, the stock has jumped as high as $0.04 and is now trading in a channel nearly 50% higher than where it was trading at toward the beginning of the year. Considering the last two financial related announcements discussed noticeable growth, this could be the trend to watch for with this company in 2017.

Corbus pharma(CRBP)

Corbus Pharma actually has no direct engagement with medical or recreational marijuana sales. They are focused on developing a non-psychoactive synthetic drug that imitates the health benefits caused by the bodies reaction to CBD, Resunab. Currently in phase 3 testing, the drug is said to be release in 2019 and will be a huge driver for this $400-million cap company.

Over the last 3 months Corbus stock price has been experiencing volatile movements, dropping to 6.4 dollars in mid-February. However, the stock has been steadily increasing since. Corbus could be a good purchase because of its inelasticity to the stock prices of other marijuana stocks after possible government regulation. This offers a level of diversity which could prove to be extremely advantageous especially with the change of government in November.

mCig, Inc. (MCIG)

Since it was trading around 2 and a half cents in September, MCIG has seen highs of as much as $0.505.  The stock has been upholding a channel roughly between $0.30 and $0.40 for the last few weeks and multiple announcements show, in our opinion, that company’s focus on building shareholder value including triple digit sales growth, canceling 20 million shares  and converting another 60 million shares into preferred that also carry with it a 2 year lock up.  The company has also announced that it will be reporting on its “record financial growth numbers and cost basis investments; to include, Vapolution, VitaCBD, Omni Health (OTC PINK: OMHE,) Agri-Contractors, and other strategic partnerships.”

This week MCIG filed its 3rd Quarter financial reports showing significant growth for the company including:

  • Revenue increased 446% to $1,362,689 compared to $249,641
  • Gross profit increased 239% to $288,230 compared to $85,076
  • Expenses decreased 27% to $97,052 compared to $133,236
  • Cash and cash equivalents increased 422% to $420,888 compared to $80,542
  • Current assets increased 1,241% to $1,259,689 compared to $93,930

Cara Therapeutics(CARA)

Founded in 2004, Cara therapeutics was an interesting stock to watch over the past year. They are currently in the preclinical trials of creating a CBD compound that can be used for treating neuropathic and inflammatory pains, a market usually only tainted with opioids.

Despite their stock price drop over 62 percent in 2016, Cara has been steadily climbing since, in the first 2 months of 2017 the stock price managed to skyrocket by 186% ($9-$16.72). Their recent expansions into the pain-relief industry could become a huge catalyst for their growth, especially as the market starts to accept CBD as a healthier alternative to addictive opiate-based painkillers.

Advantis Corp. (ADVT)

We started watching Advantis Corp. (ADVT)  last summer. There’s enough going on here in our opinion to take notice of including the recent announcements that the company has taken steps to become a fully-reporting public company as well as launched distribution of topical cannabis roll-on and Tinctures to treat pain conditions. This also comes as the company has begun to further expand on its overall product offering so just like we cited at first “way back when” with Totally Hemp Crazy, we think that ADVT could be another company to follow during its infancy.  Since we picked back up on this, we’ve also watched as ADVT climbed from around $0.005 to highs of $0.035 during the last full week of February.

This week the company announced that it has received the first orders for Hemperor’s Club, Elixicure and Deltacure products from California’s largest medical marijuana delivery service, Speedweed. The delivery service has asked Advantis to participate as a Premiere Guest of Speedweed at the Cannabis Business Expo this week.

Insys therapeutics (INSY)

Insys therapeutics, is a specialty pharmaceutical company that has started their venture into the cannabis industry over the past year. Just recently the FDA green lit the pharmaceutical giants reformulation of the longest standing marijuana based medicine, marinol. Originally created by ABBvie incorporation, the reformulated medicine (Now syndros) is an effective and healthy way to treat millions of cancer patients who suffer from nausea from Chemotherapy sessions, Also doubling as a treatment for the lack of appetite in aids patients. According to studies done by Insys, Sydros is said to eventually generate peak annual sales of roughly 200 million dollars, only 20 million dollars less than their top selling opioid painkiller Subsys.

Although the stock price hit a trough in the middle of December of 2016 due to an ongoing court case, It a poised them for growth in the next year. While there still hasn’t been a definite outcome in the settlement of the cases, The Small-Cap pharmaceutical companies’ price has steadily been increasing since the incident. Their new change in management combined with their recent developments in the cancer relief industry might prove them to be an extremely interesting stock to watch in 2017.

Gw Pharma (GWPH)

Judging by the fact that you are reading this article, chances are that you have heard about the next stock, British medical marijuana giant GW pharma. Founded in 1998, The English pharmaceutical company has been specializing in creating CBD-based prescription medicines for their widespread international consumers. The company’s Key product is Sati vex, an oromucosal spray for the treatment of cancer pain, Multiple Sclerosis and neuropathic pain. Just recently, GW pharma submitted their request to formulate medicine Epidiolex, Created to treat the 2 million people who suffer from epilepsy in the united states. This vast consumer base has set projected peak annual sales from $300 million to $3 Billion. The main question at hand is whether they will be able to maintain this level of steady growth. Although the price had been stagnant, following a small decrease in price a month ago the stock has been steadily increasing, The true results will begin to shine as they begin to sell their breakthrough medicine, Epidiolex.

AbbVie (ABBV)

Best known for their “miracle” arthritis drug Humira (The top Selling drug in the world), their new developments into the CBD industry will prove to be something to monitor for the growth of this company’s market cap. Their latest cancer-relief medicine Venclexta, is projected to reap in at least 1.5 billion dollar’s worth of annual sales in the next year.

Like most companies in the Medicinal Marijuana industry, AbbVie faced a giant drop in stock price in November because of regulation skepticism as a result of the election of United States President Donald Trump. They still, however, continue to grow their revenue and earnings by double digit numbers, not to mention an attractive dividend yield of 4.2%. Collectively with their relatively cheap stock price and their recent advances into the CBD and autoimmune industries, this stock will be very interesting to watch in 2017.

AXIM Biotech (AXIM)

Axim Biotech recently announced their plans of improving their patent for the worlds first CBD chewing gum. The small-cap pharmaceutical company decided to take an interesting approach to the widespread intake of CBD for medication purposes. Furthering their customer-base, AXIM has engaged in new studies to test the benefits of cannchew from IBS patients to sclerosis patients, this increase consumer base will be a huge driver in their performance in 2018.

Despite their growth over the past 2 years, AXIM is still not a profitable company, closing out 2016 with $870,000, just shy of their $1.5 million debt. Their stock price spiked in mid January after this announcement at the JP Morgan Health Care Conference, the stock then fell down to 9 dollars thereafter. Their execution of their strategies over the next year will be the real facilitator of the outcome of the companies overall success.

HEMP incorporated (HEMP)

HEMP Inc, longer standing marijuana/CBD stocks on this list is set on becoming the market leader in the widespread distribution and use of hemp products in the world. Although their prime focus was the prevalent cultivation of hemp, HEMP Inc. has enacted new plans to build over 500 acres of farm land, made simply for the production of CBD products, due to its continuously widespread legal adaptation across the united states.

Due to their experience in the industry, their ventures will mostly be a product of their established market presence in our opinion. One thing to keep watch on are the fraud claims that have been filed against HEMP Inc. CEO, Bruce Perlowin. The stock price took a hit just days after President Trump’s secretary Spicer gave his remarks about the future of legal marijuana. Despite this temporary downfall, HEMP continues to stay the course, trading between $0.03 and $0.04 during early March.

Zynerba Pharmaceuticals (ZYNE)

Founded in 2007, Zynerba pharmaceuticals have developed a steady focus in commercializing the widespread use of synthetic cannabinoids through transdermal(skin) delivery. The company is currently studying their product ZYN001 which target Fibrositis and neuritis patients, two epidemics that generate over 6 million cases in the United States alone. The CBD is delivered through a patch that is intended for application to the back, arm and thigh.

In mid-January, Zynerba announced that they will be selling 2.8 million shares at a 25% discount of the original $22.4 in order to raise money for the phase 3 development of their products. The trajectory of this firm will most likely be based on how quickly they receive acceptance from the FDA (projected Q1 of 2018) and the overall performance of their new products on the market. As of today, The stock price has been steadily increasing and has actually reached its highest point on February 15th.

Obviously these are just a few of the CBD stocks to watch but will be a list that we’ll continue to monitor and if necessary update.  If you’ve just come to, we’ve been covering the CBD industry specifically for the last few months considering its place in the legal arena.

Despite the recent negative reactions due to certain  statements made by the secretary of the White House we think the marijuana industry will continue to grow. The industry’s revenue increase in 2016 and the endless advantages green-states like Colorado have assumed since legalization are proof that Medicinal Marijuana is an industry that can provide great advantages.

The bright side in this is that traders can use these negative (government-caused) movements in the stock prices as methods to look at some of these stocks at lower levels. The recent medical findings in CBD research, have created an entire new sector to the Marijuana industry. Judging by its growth over the past 4 years, we think that this could prove to be one of the main drivers in its success.


Pursuant to an agreement between MAPH and Ubiquitech Software Corp., we were hired for a period beginning November 11 2016 and ending May 11, 2017 to publicly disseminate information about (UBQU) including on the Website and other media including Facebook and Twitter. We are being paid $0 (CASH) for or were paid “10 million” shares of restricted common shares. MAPH owns 6 million restricted shares of Hemp, Inc. We may buy or sell additional shares of (HEMP, UBQU) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information.PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER.

0 1417

American Green Smart Vending System Unveiled to the Public on April 19th in Las Vegas at the Largest Machine Industry Event (NAMA) in America

American Green’s system is unique for three important reasons, all of which will be on display:

  • The market-leading interface is in use already and can be seen here: which many consider the most sophisticated operating system for smart retail currently available in the world.
  • American Green’s patent-protected process, created to enable the vending of controlled or age-restricted products has been designed to be ‘as good as a human.’
  • And lastly, to demonstrate the strength and versatility of American Green’s system, there will be machines from three manufacturers side by side, something that until now has not been seen in the relatively new market of smart vending combined with secure purchasing.

The biometric verification portion of the system is utilized by the US military and many large corporations who require top-notch security for identification prior to entering a facility. In addition to all of this, the entire system can be accessed via an app which allows remote purchasing in participating machines. Upon arrival at the physical machine, patrons login to their account, verify with the biometric control, and simply display the QR code on their smartphone to retrieve the product or products they purchased.

“American Green and our technology partner, PanPacific, have been working non-stop to improve this process for over four years now. The adoption of smart phones, familiarity with apps on those phones, and improvement in related vending technologies have now merged with a concept that the public could easily grasp before but are much more prepared to use now,” said David Gwyther, chairman and acting president at American Green. “Creating a process that allows flexibility in the machine selected by clients yet permitting verified accounts to login to the machines of any companies who choose to participate will grow adoption faster and simplify use by all parties. A baseball fan could buy a beer at the game in New York and cannabis from a dispensary in California the next day through the same app utilizing their verified account. This is a huge step forward for smart retail and the automated sale of regulated products,” Mr. Gwyther concluded.

In other news, the Company’s mobile app (available here: which can be shared with others and added to your phone’s screen, has been updated with a new survey. The new survey is focused on the use of smart vending for regulated purchases which should provide interesting and timely results for the NAMA show. The results of the first survey can be found here and will soon be visible on the company’s website at

Don’t Forget to Stop by American Green Store

Be sure to visit the Company Store for great American Green’s Amazon Store for clothing and apparel. Just click here: to get there. Also, find some of the finest CBD products at the company’s own store here: Also, click over to the company’s website at and sign up for the company’s EMAIL ALERTS to stay current on news. The company has over 6,600 shareholders and interest-holders on its private list and the list is growing every month. In addition, shareholders can join in the conversation about American Green here:


Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company’s Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.

0 1686

People always used to say that if you drank milk, it would help your bones grow. Well now, studies have showed that cannabis might have a similar impact. While people have been using cannabis for ages both medicinally and recreationally, only recently have the other effects of cannabis come to light. One of the most important development is the discovery of the “endocannabinoid system,” a collection of chemical pathways found in mammals whose existence wasn’t demonstrated until the 1990s.

This system is made of specific receptors that are affected by chemicals in our body-the endocannabinoids. Many of the chemicals in cannabis known as “phytocannabinoids”, are almost identical to the endocannabinoids present in our bodies. Therefore, the cannabis chemicals can also affect these receptors if they make their way into your bloodstream.

One of the most well-known chemical is THC (tetrahydrocannabinol) which creates the psychoactive “high” people desire when they use the drug for recreation. Other research has discovered other phtyocannabinoids that do not produce the psychoactive effect, but show therapeutic potential. The most prominent of these other chemicals is CBD (cannabidiol), which has been proven to show strong pain-relieving and anti-inflammatory properties, and also has been shown to essentially stop seizures caused by the neurologic condition Dravet’s Syndrome.

Scientists performed a study involving these chemicals to see how it affected broken femurs in laboratory rats. They found that CBD increased the strength of healed broken femurs. They found CBD to be most effective with other constituents removed. CBD increases the expression of a gene that results in a higher production of collagen, which creates harder bone material, a process named collagen cross-linking.
What is interesting is that, the CBD specifically has more therapeutic effect than the cannabis plant as a whole. Therefore, consuming canna

cannabis as a whole would not be nearly as effective as consuming the CBD itself. To be most effective a treatment would require the isolation or concentration of CBD and the removal or reduction of THC.
There is still much to be studied on this matter, but there are hopes that this could help strengthen human bones in the future.

0 1655

Cannabis has never been a “for-profit” industry in any country on earth; at least not until United States voters made it one. According to Gallup polls; the end of the cannabis prohibition seems almost inevitable considering a record 61 percent of Americans support legal adult use, but many questions remain unanswered. How will cannabis be sold and advertised? How will marijuana sales be regulated? Who will dominate the markets? Will weed be changed? If so, how? Finally, how do we know the legal sale of cannabis will not create a disaster?

These questions do not have simple answers, but CBSN set out to address them by traveling to Canada as well as five states and interviewing people on all sides of the issue from consumers to sellers, lobbyists to elected representatives. At one point Dan Riffle was one of the nation’s most influential activist for cannabis legalization. Riffle is now against what he views as a commercial takeover of the industry and the creation of a market which depends on marijuana abusers and children.

“Legalization is happening, you know, for the first and only time,” he said. “And it seems like instead we’re just going to do alcohol again. We’re just going to do tobacco again. We’re just going to create this big, commercial model.”

Once long-time supporter of legalization and professor of public policy at New York University; Mark Kleiman, shares Riffle’s concerns. “We’re lurching from prohibition to the most wide-open kind of legalization,” he said. “Probably a bad idea.”

Mason Tvert; Riffle’s former colleague at the Marijuana Policy Project, disagrees big time. Earl Blumenauer, a congressman from Oregon, and the leading voice for marijuana legalization nationwide also disagrees big time. They both argue that there is already a “Big Pot” –the Mexican drug cartels. They emphasize that what is actually frightening is not high profits and declining public health; rather criminal gangs selling a product that is not safe and the heartless criminal justice system putting people behind bars for consuming it.

“What’s scary is that we are destroying lives. What’s scary is we can’t protect children now. What’s scary is that we are subsidizing Mexican drug cartels,” Blumenauer said.

“What’s scary is that the unaccompanied minors that are flooding into the United States are here because of the disruption in Central America and the destabilization in Mexico. … African-American young men are four times more likely to be arrested or hassled for something that most Americans now think should be legal. Now those are things that are scary now! Those are things that are wrong now!”

Brendan Kennedy is an important person in the evolving landscape of legal pot as well as CEO of Privateer, a holding company for mainstream marijuana brands. He is the first marijuana entrepreneur to get over $100 million from investors including backers in Facebook, Spotify and SpaceX. He desires for Americans to trust him to sell weed responsibly.

Kennedy answered questions such as “Is there a trade-off in this industry between profits and public health?” and “Does it concern you that according to federal data, over 4 million Americans meet the criteria for cannabis abuse or dependence?”

Kennedy believes cannabis consumers will benefit because they will have access to a safer and better regulated product. He also feels that consumers of marijuana will benefit from access to a wider variety of cannabis-based products.

“I think that most people in the United States who want to consume cannabis are already consuming it,” he said. “It will be interesting to see how the different products lower the percentage of people who actually consume via smoke. I think we’ll see other form factors that will be far more appealing from a health perspective than actually smoking cannabis. … I know more than a dozen elite athletes who consume cannabis. But they’re not consuming a joint. They’re vaporizing. They’re using cannabis as a topical for sore muscles.”

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact
Ad Placements